COMPOUND PROFILE / PROTEINS & BIOLOGICS
KER-065.
Research draftKER-065 is an investigational activin-receptor ligand-trap biologic.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
KER-065 is an investigational activin-receptor ligand-trap biologic.
Mechanism
It is designed to affect myostatin and activin-related signalling relevant to muscle.
Human research
The developer reports phase 1 healthy-volunteer data; further disease-specific studies are separate evidence.
Preclinical & other research
Preclinical work explored muscle and metabolic responses.
Safety & unknowns
Short early exposure cannot settle long-term or disease-specific risks.
Regulatory status
Investigational; avoid confusing KER-065 with other Keros programmes and their safety events.
Reported use & evidence
The supplied KER-065 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.